Viviane Bremer

3.0k total citations
117 papers, 1.8k citations indexed

About

Viviane Bremer is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Viviane Bremer has authored 117 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Epidemiology, 49 papers in Infectious Diseases and 30 papers in Microbiology. Recurrent topics in Viviane Bremer's work include HIV/AIDS Research and Interventions (39 papers), Reproductive tract infections research (30 papers) and HIV, Drug Use, Sexual Risk (29 papers). Viviane Bremer is often cited by papers focused on HIV/AIDS Research and Interventions (39 papers), Reproductive tract infections research (30 papers) and HIV, Drug Use, Sexual Risk (29 papers). Viviane Bremer collaborates with scholars based in Germany, Sweden and United Kingdom. Viviane Bremer's co-authors include Ulrich Marcus, Osamah Hamouda, Klaus Jansen, Akihiro Tojo, Ruth Zimmermann, Thomas Meyer, Heiko Jessen, Masao Omata, Christopher S. Wilcox and Tadashi Ogawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Viviane Bremer

113 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viviane Bremer Germany 25 769 573 448 376 277 117 1.8k
Noah Jamie Robinson United Kingdom 22 1.3k 1.7× 529 0.9× 337 0.8× 348 0.9× 182 0.7× 41 2.3k
Annie‐Claude Labbé Canada 31 1.2k 1.6× 1.2k 2.1× 189 0.4× 316 0.8× 173 0.6× 114 2.5k
Nicolas Nagot France 31 2.2k 2.8× 1.3k 2.3× 160 0.4× 357 0.9× 304 1.1× 212 3.6k
Beverly E. Sha United States 29 1.1k 1.4× 828 1.4× 202 0.5× 786 2.1× 140 0.5× 84 2.4k
Florence Lot France 22 1.2k 1.6× 1.4k 2.5× 153 0.3× 210 0.6× 340 1.2× 68 2.1k
Anne F. Luetkemeyer United States 20 863 1.1× 851 1.5× 222 0.5× 218 0.6× 490 1.8× 58 1.5k
Phillip Hay United Kingdom 34 1.6k 2.1× 805 1.4× 602 1.3× 2.0k 5.2× 73 0.3× 116 4.3k
Josip Begovać Croatia 21 649 0.8× 679 1.2× 74 0.2× 136 0.4× 126 0.5× 111 1.3k
Tsehaynesh Messele Ethiopia 24 609 0.8× 962 1.7× 174 0.4× 53 0.1× 158 0.6× 64 1.8k
Gilles Delage Canada 27 842 1.1× 611 1.1× 93 0.2× 193 0.5× 318 1.1× 114 2.2k

Countries citing papers authored by Viviane Bremer

Since Specialization
Citations

This map shows the geographic impact of Viviane Bremer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viviane Bremer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viviane Bremer more than expected).

Fields of papers citing papers by Viviane Bremer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viviane Bremer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viviane Bremer. The network helps show where Viviane Bremer may publish in the future.

Co-authorship network of co-authors of Viviane Bremer

This figure shows the co-authorship network connecting the top 25 collaborators of Viviane Bremer. A scholar is included among the top collaborators of Viviane Bremer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viviane Bremer. Viviane Bremer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sperle, Ida, Zuridin Sharipovich Nurmatov, Stela Bivol, et al.. (2025). Barriers and Facilitators to HIV and Viral Hepatitis Testing in Primary Health Care Settings in the Kyrgyz Republic (BarTest): Protocol for a Mixed Methods Study. JMIR Research Protocols. 14. e62929–e62929. 1 indexed citations
2.
3.
Bremer, Viviane & Anastasia Pharris. (2024). Five years to 2030: reaching underserved populations is key to ending the AIDS epidemic in Europe. Eurosurveillance. 29(48). 2 indexed citations
4.
Kollan, Christian, Barbara Gunsenheimer‐Bartmeyer, Björn‐Erik Ole Jensen, et al.. (2023). AIDS in the era of antiretroviral therapy: Changes in incidence rates and predictors of AIDS among people living with HIV under clinical care in Germany, a cohort study 1999–2018. HIV Medicine. 24(7). 794–806.
5.
Koppe, Uwe, Ulrich Marcus, Stefan Albrecht, et al.. (2021). Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany. BMC Public Health. 21(1). 159–159. 27 indexed citations
6.
Nielsen, Stine, Matthias an der Heiden, Viviane Bremer, et al.. (2020). Technical protocol for hepatitis C prevalence surveys in the general population. 2 indexed citations
7.
Stecher, Melanie, Jörg Janne Vehreschild, Barbara Gunsenheimer‐Bartmeyer, et al.. (2020). Rapid Uptake of Pre-Exposure Prophylaxis After Significant Price Reduction in Germany Highlights Importance of Pre-Exposure Prophylaxis Accessibility. AIDS Research and Human Retroviruses. 36(9). 721–733. 5 indexed citations
8.
Steffen, Gyde, Ida Sperle, Siv Aina J. Leendertz, et al.. (2020). The epidemiology of Hepatitis B, C and D in Germany: A scoping review. PLoS ONE. 15(3). e0229166–e0229166. 11 indexed citations
9.
Dudareva, Sandra, et al.. (2020). Virushepatitis B und D im Jahr 2019. Robert-Koch-Institut (RKI). 3 indexed citations
10.
Hauser, Andrea, Matthias an der Heiden, Karolin Meixenberger, et al.. (2019). Evaluation of a BioRad Avidity assay for identification of recent HIV-1 infections using dried serum or plasma spots. Journal of Virological Methods. 266. 114–120. 6 indexed citations
11.
Wang, Bo, Luise Krüger, Patrycja Machnowska, et al.. (2019). Characterization of a hepatitis C virus genotype 1 divergent isolate from an HIV-1 coinfected individual in Germany assigned to a new subtype 1o. Virology Journal. 16(1). 28–28. 6 indexed citations
12.
Buder, Susanne, et al.. (2018). Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance. BMC Infectious Diseases. 18(1). 44–44. 22 indexed citations
13.
14.
15.
Hauser, Andrea, Ruth Zimmermann, Claudia Hövener, et al.. (2017). Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014. BMC Infectious Diseases. 17(1). 484–484. 25 indexed citations
16.
Nielsen, Stine, Norbert Bannert, C.–Thomas Bock, et al.. (2016). Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany. PubMed. 1(1). 8–8. 11 indexed citations
17.
Schenkel, Karl, et al.. (2008). Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups. BMC Public Health. 8(1). 132–132. 37 indexed citations
18.
Bremer, Viviane. (2005). Infektionsepidemiologische Ausbildungs- und Trainingsprogramme. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 48(9). 1049–1054. 4 indexed citations
19.
Bremer, Viviane, et al.. (2005). Consumption, Knowledge, and Handling of Raw Meat: A Representative Cross-Sectional Survey in Germany, March 2001. Journal of Food Protection. 68(4). 785–789. 21 indexed citations
20.
Cotter, Benvon, et al.. (2003). Assessment of neonatal tetanus elimination in an African setting by lot quality assurance cluster sampling (LQA–CS). Epidemiology and Infection. 130(2). 221–226. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noah Jamie Robinson Breakdown of academic impact, for papers by Annie‐Claude Labbé Breakdown of academic impact, for papers by Nicolas Nagot Breakdown of academic impact, for papers by Beverly E. Sha Breakdown of academic impact, for papers by Florence Lot Breakdown of academic impact, for papers by Anne F. Luetkemeyer Breakdown of academic impact, for papers by Phillip Hay Breakdown of academic impact, for papers by Josip Begovać Breakdown of academic impact, for papers by Tsehaynesh Messele Breakdown of academic impact, for papers by Gilles Delage
Rankless by CCL
2026